Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-08 · accession 0001870913-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-03-11 | 2024-03-08 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $67.17 | -10.0K | 832.6K | -1% | -$671.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | S | D | 10,000 | $67.17 | 832,620 | I Held by Esjay LLC | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $66.51 to $67.81, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |